Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007196
Chunk: 130

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 130
---
 of the Securities Act of 1933, as amended, this Registration
Statement on Form F-1 has been signed by the undersigned on this 8th day of May, 2025.

| By:    | /s/ Donald J. Puglisi                          |
| Name:  | Donald J. Puglisi                              |
| Title: | Authorized Representative in the United States |

| II-6 |

<div align='center'>Exhibit Index</div>

| Exhibit 
 Number  
 3.1     
 4.1     | Title                                                                                                                                                                                                                                                                                                                                                                                         
 Articles of Association of Biodexa Pharmaceuticals PLC, adopted on November 22, 2024 (incorporated by reference to Exhibit 1.1 to the Company’s Report on Form 6-K, filed with the SEC on December 27, 2024).                                                                                                                                                                                 
 Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to Exhibit 2.1 to the Company’s Annual Report on Form 20-F, filed with the SEC on April 11, 2025).                                                                                                                                                                                       |
|:--------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 4.2     | Specimen certificate representing ordinary shares of Biodexa Pharmaceuticals Plc (incorporated by reference to Exhibit 4.2 to the Company’s Registration Statement on Form F-1 (File No. 333-272693), filed with the SEC on June 16, 2023).                                                                                                                                                   |
| 4.3     | Form of Second Amended and Restated Deposit Agreement by and among Biodexa Pharmaceuticals PLC, JPMorgan Chase Bank, N.A., as depositary, and all owners and holders from time to time of American Depositary Shares thereunder (incorporated by reference to Exhibit (a) to the Company’s Registration Statement on Form F-6 (File No. 333-275909), filed with the SEC on December 6, 2023). |
| 4.4     | Form of JPMorgan Chase Bank, N.A. American Depositary Receipt (included in Exhibit 4.5 as Exhibit A thereto).                                                                                                                                                                                                                                                                                 |
| 4.5     | Form of Warrant issued on October 25, 2019 (incorporated by reference to Exhibit 4.1 of the Company’s Report on Form 6-K, filed with the SEC on October 24, 2019